Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 19.33%181.83B | 18.99%671.21B | 16.27%152.38B | 1.20%564.09B | 1.30%142.55B | 1.49%150.5B | -0.35%139.99B | 2.44%131.05B | 28.49%557.41B | 23.56%140.72B |
| Cost of revenue | 24.08%158.39B | 23.02%591.98B | 13.98%127.65B | -0.81%481.23B | -1.57%120.99B | 0.79%129.61B | -3.06%118.63B | 0.65%112B | 32.01%485.17B | 25.53%122.92B |
| Gross profit | -5.17%23.44B | -4.38%79.23B | 29.75%24.72B | 14.69%82.86B | 21.10%21.56B | 6.06%20.89B | 18.03%21.36B | 14.43%19.05B | 8.95%72.24B | 11.45%17.81B |
| Operating expense | 7.64%18.6B | 7.25%69.33B | 11.71%17.28B | 5.45%64.64B | 3.86%16.24B | 5.06%16.79B | 4.79%16.14B | 8.35%15.47B | 19.49%61.3B | 21.33%15.64B |
| Selling and administrative expenses | --19.35B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -General and administrative expense | --19.35B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other operating expenses | --181M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total other operating income | --934M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | -34.93%4.84B | -45.67%9.9B | 107.59%7.44B | 66.47%18.21B | 145.70%5.32B | 10.37%4.1B | 93.83%5.22B | 50.97%3.58B | -27.10%10.94B | -29.85%2.16B |
| Net non-operating interest income (expenses) | -24.67%-1.61B | -142.62%-5.57B | -154.53%-1.29B | -8.81%-2.3B | 30.81%-595M | 5.33%-586M | -50.12%-608M | -123.79%-508M | -413.63%-2.11B | -362.37%-860M |
| Non-operating interest income | 127.80%508M | -5.51%961M | -31.60%223M | 125.00%1.02B | 135.53%179M | 149.54%272M | 81.82%240M | 141.48%326M | -20.14%452M | -18.28%76M |
| Non-operating interest expense | 39.84%2.12B | 97.16%6.53B | 81.77%1.52B | 29.30%3.31B | -17.31%774M | 17.86%858M | 57.91%848M | 130.39%834M | 162.33%2.56B | 235.48%936M |
| Net investment income | -273.39%-189M | 150.00%190M | -71.16%109M | 120.29%71M | -2,562.50%-213M | 235.66%175M | -91.21%76M | 380.00%378M | 13.58%-350M | |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 2,513.16%917M | -180.00%-8M | -108.90%-38M | -111.48%-49M | 0 | 1M | 10M | 10.91%427M | 427M | |
| Income from associates and other participating interests | -58.90%120M | 32.03%1.32B | 56.15%292M | -1.09%996M | -20.36%446M | 28.06%251M | 12.00%112M | 23.84%187M | 599.31%1.01B | 667.12%560M |
| Special income (charges) | -129.22%-369M | -100.42%-51M | 690.19%1.26B | -578.09%-1.21B | -22,534.09%-9.96B | 575.47%252M | 19,862.30%12.18B | -113.85%-214M | -122.33%-178M | |
| Less:Restructuring and mergern&acquisition | ---- | -98.00%18M | --18M | 897.78%898M | ---- | ---- | ---- | ---- | -62.81%90M | ---- |
| Less:Other special charges | ---- | 101.93%238M | 100.27%33M | -10,054.84%-12.34B | 104.55%180M | -315.91%-95M | -575.47%-252M | -19,862.30%-12.18B | 106.78%124M | 111.04%88M |
| Less:Write off | ---- | -96.96%113M | ---- | --3.72B | --53M | ---- | ---- | ---- | --0 | --0 |
| Less:Negative goodwill immediately recognized | ---- | ---- | ---- | --6.47B | --76M | ---- | ---- | ---- | --0 | --0 |
| Other non-operating income (expenses) | 37.66%-144M | -75.76%-116M | 56.00%-231M | 61.81%-76M | 18.52%-220M | 149.06%131M | -131.28%-66M | -52.17%-525M | -243.10%-199M | |
| Income before tax | -48.09%3.35B | -67.53%5.85B | -58.26%6.45B | 81.91%18.02B | 149.90%3.91B | -323.42%-6.63B | 172.96%5.28B | 349.71%15.46B | -39.20%9.9B | -54.10%1.56B |
| Income tax | -95.99%54M | -75.31%2.07B | -69.16%1.35B | 123.28%8.37B | 430.69%2.08B | -67.16%400M | 165.00%1.54B | 179.37%4.36B | -19.11%3.75B | -67.52%391M |
| Net income | -35.49%3.3B | -60.76%3.78B | -53.97%5.11B | 56.71%9.64B | 56.14%1.83B | -501.71%-7.03B | 176.50%3.74B | 491.37%11.1B | -47.21%6.15B | -46.75%1.17B |
| Net income continuous operations | -35.49%3.3B | -60.77%3.78B | -53.97%5.11B | 56.70%9.64B | 56.23%1.83B | -501.77%-7.03B | 176.37%3.74B | 491.37%11.1B | -47.20%6.15B | -46.75%1.17B |
| Noncontrolling interests | -89.32%47M | -50.21%1.55B | -78.31%440M | 12,368.00%3.12B | 160.75%279M | 525.88%362M | 3,080.00%447M | 11,172.22%2.03B | -83.11%25M | 67.19%107M |
| Net income attributable to the company | -30.42%3.25B | -65.82%2.23B | -48.53%4.67B | 6.50%6.52B | 45.86%1.55B | -502.89%-7.39B | 140.69%3.3B | 388.16%9.07B | -46.75%6.13B | -50.19%1.06B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -30.42%3.25B | -65.82%2.23B | -48.53%4.67B | 6.50%6.52B | 45.86%1.55B | -502.89%-7.39B | 140.69%3.3B | 388.16%9.07B | -46.75%6.13B | -50.19%1.06B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -30.44%37.78 | -65.81%25.95 | -48.53%54.31 | 6.50%75.9 | 45.88%18.06 | -503.00%-86 | 140.62%38.33 | 388.02%105.51 | -46.75%71.27 | -50.20%12.38 |
| Diluted earnings per share | 0 | -65.81%25.95 | -48.53%54.31 | 6.50%75.9 | 45.87%18.054 | -503.00%-86.0006 | 140.68%38.3297 | 388.02%105.51 | -46.75%71.27 | -50.19%12.3771 |
| Dividend per share | 0 | 0.00%52 | 0 | 0.00%52 | 0.00%26 | 0 | 0.00%26 | 0 | 0.00%52 | 0.00%26 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |